Oscient Pharmaceuticals (Antara Drug)
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
2
FINANCING ROUNDS
Description
A cholesterol-lowering medicine. The drug is engaged in lowering the cholesterol level in patients. It has the generic name fenofibrate.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- 1000 Winter Street
- Suite 2200
- Waltham, MA 02451
- United States
Oscient Pharmaceuticals (Antara Drug) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Oscient Pharmaceuticals (Antara Drug)‘s full profile, request access.
Request full access to PitchBookOscient Pharmaceuticals (Antara Drug) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Oscient Pharmaceuticals (Antara Drug)‘s full profile, request access.
Request full access to PitchBook